However, excluding these two, sales were up six per cent for the month. Adjustments in the production line for changing models have influenced JLR sales in the past two months. While the share of China in the overall JLR volume pie was down to 19 per cent in February from 27 per cent year-to-date, on local manufacture and an unfavourable base, analysts expect it to gradually increase again. IDBI Capital analysts say the benefit of local production in that country will help the company be competitive in case of a slowdown.
Despite slow ramp-up (JLR sales are up about six per cent year-to-date, to about 400,000 units), analysts say volume recovery assumption for JLR is intact. They are expecting double-digit growth for JLR in FY16. JPMorgan analysts are overweight on the stock, given the aggressive product and capacity rollout programmes, with new launches that include the Discovery Sport and Jaguar XE.
The India business continues to improve, led by medium and heavy commercial vehicles (M&HCVs) and car sales, which grew 30-33 per cent in February, pushing overall growth in the month to 11 per cent. Truck sales over the past six months have done well due to falling diesel prices and increasing freight rates. Diesel prices account for about half the operating cost for transport companies and the steep drop in prices is expected to improve their profitability. Truck operators have started to replace their older fleet, postponed during the earlier downturn, to meet the demand uptick.
Given the company's focus on reviving passenger car sales and the launch of the Zest in September 2014 and the Bolt in end-January 2015, sales of cars have seen a spurt in recent months, with the year-to-date numbers registering a 19 per cent increase. On the back of higher Zest sales (4,000 units a month) and those of the Bolt, car volumes are expected to grow a strong 21 per cent in FY15 and 23 per cent in FY16.
The two areas of concern on India sales have been the slower sales of light CVs and utility vehicles (UVs), tracking the sluggish sector sales. While lack of new products means UV sales (down 21 per cent year-to-date) will continue to be sluggish, light CVs (down 30 per cent over a year) are expected to recover. They generally lag the recovery of M&HCVs by two to three quarters.
With key segments recovering, analysts expect the domestic business to show strong revenue growth of 20-plus per cent (versus low single-digit growth in FY15) and break-even at the operating level for FY16 (loss in FY14 and FY15).
Given the better growth in JLR sales and improving domestic sales, nearly 90 per cent of the analysts covering the stock have a 'Buy' rating. Although India sales are expected to recover, 85 per cent of the one-year forward sum-of-the-parts valuation of Rs 635-650 is accounted by JLR. Any further weakness (current market price at Rs 560) should be an attractive entry point.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)